Effect of rpoB Mutations Conferring Rifampin Resistance on Fitness of Mycobacterium tuberculosis
Rifampin is a major drug used in the treatment of tuberculosis infections, and increasing rifampin resistance represents a worldwide clinical problem. Resistance to rifampin is caused by mutations in the rpoB gene, encoding the β-subunit of RNA polymerase. We examined the effect of three different r...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2004
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC375340/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15047531/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.4.1289-1294.2004 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|